GRI - GRI Bio, Inc.
1.33
0.120 9.023%
Share volume: 124,928
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.12
0.10%
Summary score
27%
Profitability
0%
Dept financing
17%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-34.03%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
29.74%
Debt ratio change over timeo
0%
Current Ratio
3.43%
Quick Ratio
0%
Cash Position Ratio
3.07%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-34.03%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
29.74%
Debt ratio change over timeo
0%
Current Ratio
3.43%
Quick Ratio
0%
Cash Position Ratio
3.07%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-34.03%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
29.74%
Debt ratio change over time
0%
Current Ratio
3.43%
Quick Ratio
0%
Cash Position Ratio
3.07%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GRI | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 15.71% | 0% | 0% |
| Return on assets | -34.03% | 4.24% | 0% | 0% |
| Return on sales | 0% | 28.08% | 0% | 0% |
| Return on invested capital | 0% | 9.78% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 29.74% | 81.31% | 0% | 0% |
| Debt ratio change over time | 0% | -15.58% | 0% | 0% |
| Dept financing | 34% | 25% | 0% | 0% |
| Current Ratio | 3.43% | 1.25% | 0% | 0% |
| Quick Ratio | 0% | 0.96% | 0% | 0% |
| Cash Position Ratio | 3.07% | 0.13% | 0% | 0% |
| Liquididy | 50% | 35% | 0% | 0% |
| Short-term ratios | GRI | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 17.51% | 0% | 0% |
| Return on assets | -34.03% | 4.29% | 0% | 0% |
| Return on sales | 0% | 28.55% | 0% | 0% |
| Return on invested capital | 0% | 11.13% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 29.74% | 80.84% | 0% | 0% |
| Debt ratio change over time | 0% | 4.11% | 0% | 0% |
| Dept financing | 9% | 50% | 0% | 0% |
| Current Ratio | 3.43% | 1.25% | 0% | 0% |
| Quick Ratio | 0% | 0.96% | 0% | 0% |
| Cash Position Ratio | 3.07% | 0.13% | 0% | 0% |
| Liquididy | 50% | 35% | 0% | 0% |
